Market Research Logo

New Zealand Pharmaceuticals and Healthcare Report Q2 2016

New Zealand Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The free reign that New Zealand's Pharmaceutical Management Agency (PHARMAC) has overpharmaceutical spending will come under pressure. While the agency's stringent approach to listingmedicines has helped to curtail drug spending, it has limited access to novel 'first-in-class' medicines. Thisin turn has created public pressure from both patient groups and politicians that could infringe uponPHARMAC's operations. The Trans-Pacific Partnership will also have ramifications on the agency asstronger biologic protection delays the introduction of biosimilars.

Headline Expenditure Forecasts

Pharmaceuticals: NZD1.48bn (USD1.0bn) in 2015 to NZD1.51bn (USD932mn) in 2016; 2.0% in localcurrency terms and -9.8% in US dollar terms.

Healthcare: NZD23.09bn (USD16.11bn) in 2015 to NZD23.63bn (USD14.58bn) in 2016; 2.4% in localcurrency terms and -9.5% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (New Zealand 2014
2020)
SWOT
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (New Zealand 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2012
2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (New Zealand 2012
2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (New Zealand 2012
2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (New Zealand 2012
2020)
OTC Medicine Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (New Zealand 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (New Zealand 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (New Zealand 2014
2020)
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
New Zealand Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Development
Intellectual Property Issues
Pricing & Reimbursement Regime
Table: Top 20 Medicines By Ex
Manufacturer Cost To PHARMAC In The Year Ending June 2010 (NZDmn)
Table: Top 20 Medicines Reimbursed By PHARMAC According To Prescription Numbers In The Year Ending June 2010
Market Overview
Healthcare Sector
Table: Healthcare Resources (New Zealand 2010
2015)
Table: Healthcare Activity (New Zealand 2010
2015)
Table: Healthcare Personnel (New Zealand 2010
2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Douglas Pharmaceuticals
New Zealand Pharmaceuticals
Pfizer New Zealand
Demographic Forecast
Table: Population Headline Indicators (New Zealand 1990
2025)
Table: Key Population Ratios (New Zealand 1990
2025)
Table: Urban/Rural Population & Life Expectancy (New Zealand 1990
2025)
Table: Population By Age Group (New Zealand 1990
2025)
Table: Population By Age Group % (New Zealand 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report